
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations Inc. demonstrated strong financial performance in 2Q25, reporting total revenue of $11.8 million, a 58% increase that surpassed previous estimates by $1.8 million. The company benefitted from higher-than-anticipated average selling prices (ASPs) due to favorable product mix, contributing to a positive outlook for sustainable revenue growth. With an improved balance sheet and an increasing number of surgeon adopters of their implant systems, Shoulder Innovations is well-positioned for ongoing expansion in the shoulder surgical care market.
Bears say
Shoulder Innovations Inc. reported a significant adjusted EBITDA loss of $7.5 million, which exceeded prior projections by approximately $400,000, highlighting financial challenges. The company faces multiple risks, including a slower-than-expected uptake of its products among new surgeons, lower growth rates in the shoulder market, and higher-than-anticipated operating expenses, all contributing to a negative outlook. Additionally, the firm recorded a total EBITDA loss of $35.9 million, compounded by increased selling, general, and administrative expenses due to higher headcount and legal costs.
This aggregate rating is based on analysts' research of Silvergate Capital Corp and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares